Editorial commentary: Amiodarone-induced thyroid diseases: Additional unintended consequences

Affiliations

¹ The Department of Pharmacy Practice, College of Pharmacy, Purdue University, Indianapolis, IN, United States; The Division of Clinical Pharmacology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN, United States. Electronic address: jtisdale@purdue.edu.

Editorial

James E Tisdale. Trends Cardiovasc Med. 2019 Jul.

. 2019 Jul;29(5):296-297.

doi: 10.1016/j.tcm.2018.10.003. Epub 2018 Oct 13.

¹ The Department of Pharmacy Practice, College of Pharmacy, Purdue University, Indianapolis, IN, United States; The Division of Clinical Pharmacology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN, United States. Electronic address: jtisdale@purdue.edu.

No abstract available

Keywords: Amiodarone; Digoxin; Drug interactions; Hyperthyroidism; Hypothyroidism; Warfarin; p-glycoprotein.

Comment on

Amiodarone and thyroid physiology, pathophysiology, diagnosis and management.
Trohman RG, Sharma PS, McAninch EA, Bianco AC. Trohman RG, et al. Trends Cardiovasc Med. 2019 Jul;29(5):285-295. doi: 10.1016/j.tcm.2018.09.005. Epub 2018 Sep 20. Trends Cardiovasc Med. 2019. PMID: 30309693 Free PMC article.